Skip to content
REGN Regeneron Pharmaceuticals Inc NASDAQ
819.94 USD -0.01% -0.06
OPEN 821.38
DAY RANGE 832.48 - 817.87
52 WEEK RANGE 832.48 - 538.01
Interactive Brokers Logotype

Buy REGN stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 89.6B
Enterprise value 82.5B
Trailing pe 19.878788
Forward pe 18.210083
Peg ratio 18.210083
Price to sales ttm 7.3644996
Price to book mrq 3.8713393
Enterprise to revenue 6.775
Enterprise to ebitda 15.458


Fiscal year ends 2022-12-31
Most recent quarter 2022-12-31
Profit margin 0.35639998
Operating margin 0.41026002
Return on assets ttm 0.11423001
Return on equity ttm 0.20942
Income statement
Revenue ttm 12.2B
Revenue per share ttm 113.659
Quarterly revenue growth -0.31
Gross profit ttm 7B
Ebitda 5.6B
Net income to common ttm 4.3B
Diluted eps ttm 41.25
Quarterly earnings growth yoy -0.463
Balance sheet
Total cash mrq 7.7B
Total cash per share mrq 72.544
Total debt mrq 2.7B
Total debt to equity mrq 11.919
Current ratio mrq 5.057
Book value per share mrq 211.813
Cash flow
Operating cash flow ttm 5B
Levered free cash flow ttm 2.6B

Stock statistics

Shares outstanding 107.5M
Float shares 102.1M
Avg 10 volume 786.3K
Avg 30 volume 618.1K
Shares short 1.2M
Short ratio 2.28
Short percent of shares outstanding 0.0117999995
Percent held by insiders 0.02564
Percent held by institutions 0.89798

Stock price summary

Fifty two week low 538.01
Fifty two week high 824
Fifty two week change 15.433
Beta 0.2094
Day 50 ma 753.279
Day 200 ma 693.79517

Dividends and splits

Regeneron Pharmaceuticals (REGN) company profile

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products to treat severe medical conditions. Some of the firm’s products include EYLEA injection and ARCALYST injection. The company’s commercialized medicines are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases, and other rare diseases.